Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

    ... of SES on survival was more apparent for patients with refractory anemia with ringed sideroblasts-patients residing in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Historical perspectives on myelodysplastic syndromes

    ... etiology and nature of disorders described as " refractory anemia ", "preleukemia", and with other terminology ...

    Research Article last updated 10/02/2012 - 9:52am.

  3. Anemia as the Main Manifestation of Myelodysplastic Syndromes

    ... Several new agents are under evaluation for ESA refractory /relapsed MDS patients, targeting different putative mechanisms ...

    Research Article last updated 12/02/2015 - 8:45am.

  4. Aplastic anemia: therapeutic updates in immunosuppression and transplantation

    ... eltrombopag , is showing promising activity in refractory cases. The most recent advances in HSCT and IST in SAA are ...

    Research Article last updated 01/02/2013 - 2:25pm.

  5. hase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02381548 ...

    Clinical Trial last updated 05/03/2016 - 10:41am.

  6. Total Marrow Irradiation for Refractory Acute Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT00686556 ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  7. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management

    ... and iron chelation. MANAGEMENT OF PROGRESSIVE OR REFRACTORY DISEASE: At the present time, there are no approved interventions for patients with progressive or refractory disease particularly after hypomethylating based therapy. Options ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02044796 ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.

  9. Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed/Refractory Acute Leukemia or High-Risk MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02543879 ...

    Clinical Trial last updated 04/28/2016 - 9:55am.

  10. Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01729845 ...

    Clinical Trial last updated 04/28/2016 - 9:51am.